Cargando…
Hydroxychloroquine/chloroquine and the risk of acute kidney injury in COVID-19 patients: a systematic review and meta-analysis
OBJECTIVES: Hydroxychloroquine/chloroquine has been widely used as part of the standard treatment for patients with coronavirus disease 2019 (COVID-19). We conducted a systematic review and meta-analysis to determine whether hydroxychloroquine/chloroquine increases the risk of acute kidney injury (A...
Autores principales: | Liao, Zheng-Ming, Zhang, Zhong-Min, Liu, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903764/ https://www.ncbi.nlm.nih.gov/pubmed/35253579 http://dx.doi.org/10.1080/0886022X.2022.2046609 |
Ejemplares similares
-
Chloroquine and hydroxychloroquine increase risk of death in COVID-19
Publicado: (2020) -
Reported ADRs with chloroquine or hydroxychloroquine
Publicado: (2021) -
Hydroxychloroquine- and chloroquine-related cardiovascular events
Publicado: (2020) -
Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022) -
Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents
por: Verbaanderd, Ciska, et al.
Publicado: (2017)